Remove Biopharma Remove Doctors Remove Physicians
article thumbnail

Veradigm® Digital Health Media Works to Message the Right Physicians at the Right Time

PM360

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. Which physicians see these patients? sales, medical science liaisons, etc.).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Steps for More Effective HCP Marketing with Insights from Pfizer

PM360

This “synchronization” helps biopharmas such as Pfizer maximize marketing and field efforts across their organizations to improve engagement with healthcare professionals (HCPs). However, many biopharmas fail to synchronize engagement and digital touchpoints in a timely manner for 73% of HCPs.

Marketing 105
article thumbnail

Five ways COVID-19 has changed healthcare provision and what it means for pharmas

Clarivate

2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. Three in five physicians in the United States (60%) report having conducted virtual consultations, as do 35% of patients. physicians; Source: Clarivate, Taking the Pulse(R) U.S.

Pharma 52
article thumbnail

The use of genomic profiling testing to improve oncology care

pharmaphorum

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. Across LabCorp , we innovate through science and technology, with access to approximately 2,500 [doctors] and PhDs and over 700 patients.

Patients 105
article thumbnail

Genentech’s Chief Marketing Officer Talks Marketing’s New Role and Data-Driven Content

PM360

I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content.

Marketing 105
article thumbnail

Accelerating HCP engagement in Singapore using customer reference data

Veeva

Veeva OpenData provides additional insight into registrars and new doctors. Some of the largest pharmaceutical companies in the world, as well as emerging biopharma, use Veeva OpenData to increase field force effectiveness, boost productivity and enhance customer engagement. 43% said they do not have robust data management processes.

Sales 52